MRM 📈 Medirom Healthcare - Overview
Exchange: NASDAQ • Country: Japan • Currency: USD • Type: Common Stock • ISIN: US58510H1032
MRM: Massage, Therapy, Fitness, Healthcare, Beauty, Guidance, Wellness
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns, develops, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, an on-demand health monitoring smartphone application and MOTHER Bracelet for fitness applications; and preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. Web URL: https://medirom.co.jp
Additional Sources for MRM Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MRM Stock Overview
Market Cap in USD | 8m |
Sector | Consumer Cyclical |
Industry | Personal Services |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2020-12-29 |
MRM Stock Ratings
Growth 5y | -91.0% |
Fundamental | 9.47% |
Dividend | - |
Rel. Strength Industry | -1402 |
Analysts | - |
Fair Price Momentum | 0.70 USD |
Fair Price DCF | - |
MRM Dividends
No Dividends PaidMRM Growth Ratios
Growth Correlation 3m | -34.4% |
Growth Correlation 12m | -85.2% |
Growth Correlation 5y | -88.3% |
CAGR 5y | -46.81% |
CAGR/Mean DD 5y | -0.75 |
Sharpe Ratio 12m | -0.11 |
Alpha | -82.97 |
Beta | 0.39 |
Volatility | 221.21% |
Current Volume | 197.6k |
Average Volume 20d | 502.9k |
What is the price of MRM stocks?
As of December 22, 2024, the stock is trading at USD 1.22 with a total of 197,597 shares traded.
Over the past week, the price has changed by -3.03%, over one month by -57.77%, over three months by -68.67% and over the past year by -66.98%.
As of December 22, 2024, the stock is trading at USD 1.22 with a total of 197,597 shares traded.
Over the past week, the price has changed by -3.03%, over one month by -57.77%, over three months by -68.67% and over the past year by -66.98%.
Is Medirom Healthcare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Medirom Healthcare is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 9.47 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRM as of December 2024 is 0.70. This means that MRM is currently overvalued and has a potential downside of -42.62%.
Neither. Based on ValueRay Fundamental Analyses, Medirom Healthcare is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 9.47 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRM as of December 2024 is 0.70. This means that MRM is currently overvalued and has a potential downside of -42.62%.
Is MRM a buy, sell or hold?
Medirom Healthcare has no consensus analysts rating.
Medirom Healthcare has no consensus analysts rating.
What are the forecast for MRM stock price target?
According to ValueRays Forecast Model, MRM Medirom Healthcare will be worth about 0.8 in December 2025. The stock is currently trading at 1.22. This means that the stock has a potential downside of -37.7%.
According to ValueRays Forecast Model, MRM Medirom Healthcare will be worth about 0.8 in December 2025. The stock is currently trading at 1.22. This means that the stock has a potential downside of -37.7%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 0.8 | -37.7% |